scholarly journals Clinical Approach to Well-differentiated Thyroid Cancers

2012 ◽  
2003 ◽  
Vol 35 (6) ◽  
pp. 2160-2162 ◽  
Author(s):  
B Górnicka ◽  
B Ziarkiewicz-Wróblewska ◽  
M Bogdańska ◽  
P Małkowski ◽  
T Wróblewski ◽  
...  

2015 ◽  
Vol 39 ◽  
pp. S38-S39
Author(s):  
C. Pleyer ◽  
S. Sidana ◽  
O. Erik ◽  
T. Radivoyevitch ◽  
A.S. Advani ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Leila J. Mady ◽  
Michael C. Grimes ◽  
Nayel I. Khan ◽  
R. Harsha Rao ◽  
Simion I. Chiosea ◽  
...  

Author(s):  
Arvind Krishnamurthy ◽  
Vijayalakshmi Ramshankar ◽  
Kanchan Murhekar ◽  
Vidyarani Shyamsundar ◽  
Pavithra B. Desai ◽  
...  

<p><strong>Background:</strong><strong> </strong>Molecular markers are gaining increasing importance as diagnostic and prognostic tools in patients with well differentiated thyroid cancers and BRAF V600E mutation has received wide attention in this regard <strong>Aim: </strong>To evaluate the clinical value of immunohistochemistry (IHC) using anti-BRAF V600E antibody (clone RM8) for detection of the BRAF V600E mutant protein in formalin-fixed and paraffin-embedded tissues of patients with papillary thyroid carcinomas. <strong>Materials and Methods: </strong>Patients who were managed for well differentiated thyroid cancers (<em>n </em>= 79) during the years 2005 and 2006 were included in the study. We evaluated the fidelity of the RM8 antibody specific for the BRAF V600E and compared its detection accuracy to real time polymerase chain reaction (PCR), which was taken as the gold standard. <strong>Results: </strong>Mutant BRAF V600E antibody was studied in 79 tissue sections, out of which 21 (26.5%) had staining for BRAF V600E in &gt;20% of the tumour cells and these were considered positive. The BRAF staining was moderate in 10 (47.6%), strong in 9 (42.5%) and very strong in 2 (9.5%) of sections stained. There was a statistically significant concordance (<em>P </em>= 0.000) with quantitative PCR (qPCR) for BRAF mutant taken as standard. (Kappa agreement: 0.881) Further, the receiver operating characteristics (ROC) curve showed that IHC can be used as a comparable standard to the qPCR. The highest possible sensitivity of 92% and specificity of 92.6% could be achieved by considering the cytoplasmic positivity of &gt;20% of cells with moderate to strong intensity (AUC = 0.923) <strong>Conclusion: </strong>Our study has shown that BRAF V600E IHC can be done in a conventional manner using rabbit monoclonal antibody RM8 on formalin-fixed and paraffin-embedded tissues of patients with papillary thyroid carcinomas. With a comparable diagnostic accuracy to the gold standard qPCR testing and with an added advantage of being cost effective, this technology can be considered for use as a first-line method for detection of BRAF V600E mutations, especially in resource constrained settings.</p>


2017 ◽  
Vol 22 (02) ◽  
pp. 167-170 ◽  
Author(s):  
Haissan Iftikhar ◽  
Mubasher Ikram ◽  
Adnan Muhammad ◽  
Karim Nathani

Introduction The rates of thyroid cancers are on a rise, especially well-differentiated thyroid cancers. This could be partly due to newer diagnostic modalities, like high-resolution ultrasound, that can pick up smaller lesions. Differentiated thyroid cancers with distant metastases are not common, and even rarer is the initial presentation with complaints not related to the neck. Objectives The objective of this series was to study and report the unusual cases of patients with differentiated thyroid cancer with distant metastasis. There is a lack of data in the literature on these cases, and due to the rarity of such metastases, no definite treatment protocol has been defined. Methods A retrospective chart review of 1,200 cases of thyroid surgeries was performed. A total of 10 cases of well-differentiated thyroid cancer on the final histopathology exam that had initially presented with usual complaints to departments other than the Otolaryngology Department were identified. Results A total of 6 patients had papillary carcinoma, whereas 4 patients had follicular carcinoma on final the histopathology exam. Two patients presented with iliac crest lesions, 2 with vertebral lesions one each with parapharyngeal mass, supraclavicular mass, labia majora swelling and bleeding, lung, rib and neck of femur lesion. Conclusion There are still no specific guidelines on how to address these patients with differentiated thyroid cancer with distant metastasis (except for the cases of bone and lung lesions) and on which treatment should be offered in case of recurrence. More studies on the subject are required.


Sign in / Sign up

Export Citation Format

Share Document